Last updated 4 months ago

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

80 patients around the world
Available in Spain, Argentina, United States
Neurocrine Biosciences
1Research sites
80Patients around the world

This study is for people with

Dyskinesia
Cerebral Palsy

Requirements for the patient

To 70 Years
All Gender

Medical requirements

Sites

Instituto de Neurología Cognitiva (INECO)
Recruiting
Marcelo Torcuato de Alvear 1632, C1021 Cdad. Autónoma de Buenos Aires, Argentina
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy